tag:blogger.com,1999:blog-9551150.post1371823823390955771..comments2024-03-17T05:36:26.059-04:00Comments on Health Care Renewal: Bad Apple or Bad Orchard? - A Narrative of Alleged Individual Research Misconduct that Sidestepped the Pharmaceutical Corporate ContextRoy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger4125tag:blogger.com,1999:blog-9551150.post-42285551295814580602016-07-16T19:13:47.903-04:002016-07-16T19:13:47.903-04:00"One bad apple" is the institutional res..."One bad apple" is the institutional response to misconduct of its researchers when they get outed in the media. It is standard in university crisis management press releases. <br /><br />Whistleblowers will be familiar with two additional responses. The first is "We see no evidence". I got this response when I was instructed by a university investigator not to send him Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-24745691364990147262016-07-11T20:05:33.782-04:002016-07-11T20:05:33.782-04:00I doubt the drug is intended to be mind altering. ...I doubt the drug is intended to be mind altering. NY Times don't seem to get this.Anonymoushttps://www.blogger.com/profile/04826942499461550564noreply@blogger.comtag:blogger.com,1999:blog-9551150.post-1492095622852158632016-07-10T16:27:42.130-04:002016-07-10T16:27:42.130-04:00This is one example of a drug company ensuring neg...This is one example of a drug company ensuring negative data will not be seen by the healthcare professionals or the public. And Pfizer's track record on misdeeds is well documented, especially for intent to defraud, and illegal promotion for unapproved FDA indications. But they were not the only ones. Just read "Deadly Medicines and Organized Crime" by Peter Gotzsche published in J. Demmynoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-30998247033330854592016-07-08T06:31:17.430-04:002016-07-08T06:31:17.430-04:00Good post. Much about this case remains murky, not...Good post. Much about this case remains murky, not least the pharma involvement, and I hope the NYT will do a follow-up piece.Neuroskeptichttps://www.blogger.com/profile/06647064768789308157noreply@blogger.com